High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK/MVA-LACK regimen in Leishmania major BALB/c model of infection.
Heterologous vaccination based on priming with a plasmid DNA vector and boosting with an attenuated vaccinia virus MVA recombinant, with both vectors expressing the Leishmania infantum LACK antigen (DNA-LACK and MVA-LACK), has shown efficacy conferring protection in murine and canine models against...
Main Authors: | Lucas Sánchez-Sampedro, Carmen Elena Gómez, Ernesto Mejías-Pérez, Carlos Oscar S Sorzano, Mariano Esteban |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3371028?pdf=render |
Similar Items
-
Antigenicity of Leishmania-Activated C-Kinase Antigen (LACK) in Human Peripheral Blood Mononuclear Cells, and Protective Effect of Prime-Boost Vaccination With pCI-neo-LACK Plus Attenuated LACK-Expressing Vaccinia Viruses in Hamsters
by: Laura Fernández, et al.
Published: (2018-04-01) -
A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses.
by: Juan García-Arriaza, et al.
Published: (2011-01-01) -
Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
by: Magdalena Radwanska, et al.
Published: (2007-05-01) -
Lack of involvement of CD63 and CD9 tetraspanins in the extracellular vesicle content delivery process
by: Maria Laura Tognoli, et al.
Published: (2023-05-01) -
Potent HIV-1-Specific CD8 T Cell Responses Induced in Mice after Priming with a Multiepitopic DNA-TMEP and Boosting with the HIV Vaccine MVA-B
by: Beatriz Perdiguero, et al.
Published: (2018-08-01)